1
|
Fu L, Wang B, Yuan T, Chen X, Ao Y,
Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, et al: Clinical
characteristics of coronavirus disease 2019 (COVID-19) in China: A
systematic review and meta-analysis. J Infect. 80:656–665.
2020.PubMed/NCBI View Article : Google Scholar
|
2
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI View Article : Google Scholar
|
3
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
4
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Lin L, Wang X, Ren J, Sun Y, Yu R, Li K,
Zheng L and Yang J: Risk factors and prognosis for COVID-19-induced
acute kidney injury: A meta-analysis. BMJ Open.
10(e042573)2020.PubMed/NCBI View Article : Google Scholar
|
6
|
Fabrizi F, Alfieri CM, Cerutti R, Lunghi G
and Messa P: COVID-19 and acute kidney injury: A systematic review
and meta-analysis. Pathogens. 9(1052)2020.PubMed/NCBI View Article : Google Scholar
|
7
|
Wang L, Li X, Chen H, Yan S, Li D, Li Y
and Gong Z: Coronavirus disease 19 infection does not result in
acute kidney injury: An analysis of 116 hospitalized patients from
Wuhan, China. Am J Nephrol. 51:343–348. 2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Cheng Y, Luo R, Wang K, Zhang M, Wang Z,
Dong L, Li J, Yao Y, Ge S and Xu G: Kidney disease is associated
with in-hospital death of patients with COVID-19. Kidney Int.
97:829–838. 2020.PubMed/NCBI View Article : Google Scholar
|
9
|
Paek JH, Kim Y, Park WY, Jin K, Hyun M,
Lee JY, Kim HA, Kwon YS, Park JS and Han S: Severe acute kidney
injury in COVID-19 patients is associated with in-hospital
mortality. PLoS One. 15(e0243528)2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Kidney Disease: Improving global outcomes
(KDIGO). Acute kidney injury work group: KDIGO clinical practice
guideline for acute kidney injury. Kidney Int Suppl. 2:1–138.
2012.PubMed/NCBI View Article : Google Scholar
|
11
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
12
|
Kolhe NV, Fluck RJ, Selby NM and Taal MW:
Acute kidney injury associated with COVID-19: A retrospective
cohort study. PLoS Med. 17(e1003406)2020.PubMed/NCBI View Article : Google Scholar
|
13
|
Wang B, Li R, Lu Z and Huang Y: Does
comorbidity increase the risk of patients with Covid-19: Evidence
from meta-analysis. Aging (Albany NY). 12:6049–6057.
2020.PubMed/NCBI View Article : Google Scholar
|
14
|
Moledina DG, Simonov M, Yamamoto Y, Alausa
J, Arora T, Biswas A, Cantley LG, Ghazi L, Greenberg JH, Hinchcliff
M, et al: The association of COVID-19 with acute kidney injury
independent of severity of illness: A multicenter cohort study. Am
J Kidney Dis. 77:490–499.e1. 2021.PubMed/NCBI View Article : Google Scholar
|
15
|
Mohamed MMB, Lukitsch I, Torres-Ortiz AE,
Walker JB, Varghese V, Hernandez-Arroyo CF, Alqudsi M, LeDoux JR
and Velez JCQ: Acute kidney injury associated with coronavirus
disease 2019 in Urban New Orleans. Kidney360. 1:614–622. 2020.
|
16
|
Xia P, Wen Y, Duan Y, Su H, Cao W, Xiao M,
Ma J, Zhou Y, Chen G, Jiang W, et al: Clinicopathological features
and outcomes of acute kidney injury in critically ill COVID-19 with
prolonged disease course: A retrospective cohort. J Am Soc Nephrol.
31:2205–2221. 2020.PubMed/NCBI View Article : Google Scholar
|
17
|
Phillips T, Stammers M, Leggatt G,
Bonfield B, Fraser S, Armstrong K and Veigheyet K: Acute kidney
injury in COVID-19: Identification of risk factors and potential
biomarkers of disease in a large UK cohort. Nephrology. 26:420–431.
2021.
|
18
|
Aggarwal S, Garcia-Telles N, Aggarwal G,
Lavie C, Lippi G and Henry BM: Clinical features, laboratory
characteristics, and outcomes of patients hospitalized with
coronavirus disease 2019 (COVID-19): Early report from the United
States. Diagnosis (Berl). 7:91–96. 2020.PubMed/NCBI View Article : Google Scholar
|
19
|
Chen J, Wang W, Tang Y, Huang XR, Yu X and
Lan HY: Inflammatory stress in SARS-COV-2 associated acute kidney
injury. Int J Biol Sci. 17:1497–1506. 2021.PubMed/NCBI View Article : Google Scholar
|
20
|
Nechemia-Arbely Y, Barkan D, Pizov G,
Shriki A, Rose-John S, Galun E and Axelrod JH: IL-6/IL-6R axis
plays a critical role in acute kidney injury. J Am Soc Nephrol.
19:1106–1115. 2008.PubMed/NCBI View Article : Google Scholar
|
21
|
Joseph A, Zafrani L, Mabrouki A, Azoulay E
and Darmon M: Acute kidney injury in patients with SARS-CoV-2
infection. Ann Intensive Care. 10(117)2020.PubMed/NCBI View Article : Google Scholar
|
22
|
Xiang HX, Fei J, Xiang Y, Xu Z, Zheng L,
Li XY, Fu L and Zhao H: Renal dysfunction and prognosis of COVID-19
patients: A hospital-based retrospective cohort study. BMC Infect
Dis. 21(158)2021.PubMed/NCBI View Article : Google Scholar
|
23
|
Su H, Lei CT and Zhang C: Interleukin-6
signaling pathway and its role in kidney disease: An update. Front
Immunol. 8(405)2017.PubMed/NCBI View Article : Google Scholar
|
24
|
Grace E and Turner RM: Use of
procalcitonin in patients with various degrees of chronic kidney
disease including renal replacement therapy. Clin Infect Dis.
59:1761–1767. 2014.PubMed/NCBI View Article : Google Scholar
|
25
|
Abbasi A, Corpeleijn E, Postmus D,
Gansevoort RT, de Jong PE, Gans RO, Struck J, Hillege HL, Stolk RP,
Navis G and Bakker SJ: Plasma procalcitonin is associated with
obesity, insulin resistance, and the metabolic syndrome. J Clin
Endocrinol Metab. 95:E26–E31. 2010.PubMed/NCBI View Article : Google Scholar
|
26
|
Gupta S, Coca SG, Chan L, Melamed ML,
Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A,
Leonberg-Yoo A, et al: AKI treated with renal replacement therapy
in critically ill patients with COVID-19. J Am Soc Nephrol.
32:161–176. 2021.PubMed/NCBI View Article : Google Scholar
|
27
|
Chen X, Yu C, Jing H, Wang C, Zhao X,
Zhang J, Zhang S, Liu H, Xie R and Shi J: COVID-19 associated
thromboinflammation of renal capillary: Potential mechanisms and
treatment. Am J Transl Res. 12:7640–7656. 2020.PubMed/NCBI
|
28
|
Ng JH, Bijol V, Sparks MA, Sise ME,
Izzedine H and Jhaveri KD: Pathophysiology and pathology of acute
kidney injury in patients with COVID-19. Adv Chronic Kidney Dis.
27:365–376. 2020.PubMed/NCBI View Article : Google Scholar
|
29
|
Beigel JH, Tomashek KM, Dodd LE, Mehta AK,
Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, et
al: Remdesivir for the treatment of Covid-19-final report. N Engl J
Med. 383:1813–1826. 2020.PubMed/NCBI View Article : Google Scholar
|
30
|
Goldman JD, Lye DCB, Hui DS, Marks KM,
Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, et
al: Remdesivir for 5 or 10 days in patients with severe Covid-19. N
Engl J Med. 383:1827–1837. 2020.PubMed/NCBI View Article : Google Scholar
|
31
|
Nasa P, Shrivastava P, Kulkarni A, Vijayan
L and Singh A: . Favipiravir induced nephrotoxicity in two patients
of COVID-19. J Assoc Physicians India. 69(90)2021.PubMed/NCBI
|
32
|
Nemchand P, Tahir H, Mediwake R and Lee J:
Cytokine storm and use of anakinra in a patient with COVID-19. BMJ
Case Rep. 13(e237525)2020.PubMed/NCBI View Article : Google Scholar
|
33
|
Langer-Gould A, Smith JB, Gonzales EG,
Castillo RD, Figueroa JG, Ramanathan A, Li BH and Gould MK: Early
identification of COVID-19 cytokine storm and treatment with
anakinra or tocilizumab. Int J Infect Dis. 99:291–297.
2020.PubMed/NCBI View Article : Google Scholar
|
34
|
Martínez-Rueda AJ, Álvarez RD,
Méndez-Pérez RA, Fernández-Camargo DA, Gaytan-Arocha JE,
Berman-Parks N, Flores-Camargo A, Comunidad-Bonilla RA, Mejia-Vilet
JM, Arvizu-Hernandez M, et al: Community- and hospital-acquired
acute kidney injury in COVID-19: Different phenotypes and dismal
prognosis. Blood Purif. 50:931–941. 2021.PubMed/NCBI View Article : Google Scholar
|
35
|
Pelayo J, Lo KB, Bhargav R, Gul F,
Peterson E, DeJoy III R, Salacup GF, Albano J, Gopalakrishnan A,
Azmaiparashvili Z, et al: Clinical characteristics and outcomes of
community- and hospital-acquired acute kidney injury with COVID-19
in a US inner city hospital system. Cardiorenal Med. 10:223–231.
2020.PubMed/NCBI View Article : Google Scholar
|
36
|
Portolés J, Marques M, López-Sánchez P, de
Valdenebro M, Muñez E, Serrano ML, Malo R, García E and Cuervas V:
Chronic kidney disease and acute kidney injury in the COVID-19
Spanish outbreak. Nephrol Dial Transplant. 35:1353–1362.
2020.PubMed/NCBI View Article : Google Scholar
|
37
|
Tarragón B, Valdenebro M, Serrano ML,
Maroto A, Llópez-Carratalá MR, Ramos A, Rubio E, Huerta A, Marques
M and Portolés J: Acute kidney failure in patients admitted due to
COVID-19. Nefrología (Engl Ed). 41:34–40. 2021.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
38
|
Peng S, Wang HY, Sun X, Li P, Ye Z, Li Q,
Wang J, Shi X, Liu L, Yao Y, et al: Early versus late acute kidney
injury among patients with COVID-19-a multicenter study from Wuhan,
China. Nephrol Dial Transplant. 35:2095–2102. 2020.PubMed/NCBI View Article : Google Scholar
|
39
|
van den Akker JP, Egal M and Groeneveld
AB: Invasive mechanical ventilation as a risk factor for acute
kidney injury in the critically ill: A systematic review and
meta-analysis. Crit Care. 17(R98)2013.PubMed/NCBI View
Article : Google Scholar
|